162 related articles for article (PubMed ID: 32245383)
1. Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL.
Lejman M; Włodarczyk M; Zawitkowska J; Kowalczyk JR
BMC Med Genomics; 2020 Apr; 13(1):58. PubMed ID: 32245383
[TBL] [Abstract][Full Text] [Related]
2. A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13).
Panagopoulos I; Micci F; Thorsen J; Haugom L; Tierens A; Ulvmoen A; Heim S
Cancer Genet; 2012 Dec; 205(12):669-72. PubMed ID: 23181981
[TBL] [Abstract][Full Text] [Related]
3. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.
Hunger SP; Li S; Fall MZ; Naumovski L; Cleary ML
Blood; 1996 Jun; 87(11):4607-17. PubMed ID: 8639829
[TBL] [Abstract][Full Text] [Related]
4. TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
[TBL] [Abstract][Full Text] [Related]
5. NGS-based methylation profiling differentiates TCF3-HLF and TCF3-PBX1 positive B-cell acute lymphoblastic leukemia.
Kachroo P; Szymczak S; Heinsen FA; Forster M; Bethune J; Hemmrich-Stanisak G; Baker L; Schrappe M; Stanulla M; Franke A
Epigenomics; 2018 Feb; 10(2):133-147. PubMed ID: 29334255
[TBL] [Abstract][Full Text] [Related]
6. A novel PAX5 rearrangement in TCF3-PBX1 acute lymphoblastic leukemia: a case report.
Barbosa TC; Lopes BA; Blunck CB; Mansur MB; Deyl AVS; Emerenciano M; Pombo-de-Oliveira MS
BMC Med Genomics; 2018 Dec; 11(1):122. PubMed ID: 30563523
[TBL] [Abstract][Full Text] [Related]
7. Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.
Fischer U; Forster M; Rinaldi A; Risch T; Sungalee S; Warnatz HJ; Bornhauser B; Gombert M; Kratsch C; Stütz AM; Sultan M; Tchinda J; Worth CL; Amstislavskiy V; Badarinarayan N; Baruchel A; Bartram T; Basso G; Canpolat C; Cario G; Cavé H; Dakaj D; Delorenzi M; Dobay MP; Eckert C; Ellinghaus E; Eugster S; Frismantas V; Ginzel S; Haas OA; Heidenreich O; Hemmrich-Stanisak G; Hezaveh K; Höll JI; Hornhardt S; Husemann P; Kachroo P; Kratz CP; Te Kronnie G; Marovca B; Niggli F; McHardy AC; Moorman AV; Panzer-Grümayer R; Petersen BS; Raeder B; Ralser M; Rosenstiel P; Schäfer D; Schrappe M; Schreiber S; Schütte M; Stade B; Thiele R; von der Weid N; Vora A; Zaliova M; Zhang L; Zichner T; Zimmermann M; Lehrach H; Borkhardt A; Bourquin JP; Franke A; Korbel JO; Stanulla M; Yaspo ML
Nat Genet; 2015 Sep; 47(9):1020-1029. PubMed ID: 26214592
[TBL] [Abstract][Full Text] [Related]
8. Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion.
Rowsey RA; Smoley SA; Williamson CM; Vasmatzis G; Smadbeck JB; Ning Y; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP; Peterson JF
Blood Cancer J; 2019 Oct; 9(10):81. PubMed ID: 31575852
[TBL] [Abstract][Full Text] [Related]
9. E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype.
Dahéron L; Brizard F; Millot F; Cividin M; Lacotte L; Guilhot F; Brizard A
Hematol J; 2002; 3(3):153-6. PubMed ID: 12111652
[TBL] [Abstract][Full Text] [Related]
10. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report.
Wafa A; As'sad M; Liehr T; Aljapawe A; Al Achkar W
J Med Case Rep; 2017 Apr; 11(1):94. PubMed ID: 28385156
[TBL] [Abstract][Full Text] [Related]
11. Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols.
Ribera J; Granada I; Morgades M; González T; Ciudad J; Such E; Calasanz MJ; Mercadal S; Coll R; González-Campos J; Tormo M; García-Cadenas I; Gil C; Cervera M; Barba P; Costa D; Ayala R; Bermúdez A; Orfao A; Ribera JM;
Br J Haematol; 2022 Feb; 196(3):670-675. PubMed ID: 34549416
[TBL] [Abstract][Full Text] [Related]
12. Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia.
Hutspardol S; Pakakasama S; Kanta K; Nuntakarn L; Anurathapan U; Sirachainan N; Songdej D; Sawangpanich R; Tiyasirichokchai R; Rerkamnuaychoke B; Hongeng S
Int J Lab Hematol; 2013 Aug; 35(4):406-15. PubMed ID: 23190578
[TBL] [Abstract][Full Text] [Related]
13. The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability.
Huang Y; Mouttet B; Warnatz HJ; Risch T; Rietmann F; Frommelt F; Ngo QA; Dobay MP; Marovca B; Jenni S; Tsai YC; Matzk S; Amstislavskiy V; Schrappe M; Stanulla M; Gstaiger M; Bornhauser B; Yaspo ML; Bourquin JP
Cancer Cell; 2019 Dec; 36(6):630-644.e9. PubMed ID: 31735627
[TBL] [Abstract][Full Text] [Related]
14. E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells.
Yeung J; O'Sullivan E; Hubank M; Brady HJ
Br J Haematol; 2004 Jun; 125(5):560-7. PubMed ID: 15147370
[TBL] [Abstract][Full Text] [Related]
15. Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein.
Matsunaga T; Inaba T; Matsui H; Okuya M; Miyajima A; Inukai T; Funabiki T; Endo M; Look AT; Kurosawa H
Blood; 2004 Apr; 103(8):3185-91. PubMed ID: 15070701
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of survivin by the E2A-HLF chimera is indispensable for the survival of t(17;19)-positive leukemia cells.
Okuya M; Kurosawa H; Kikuchi J; Furukawa Y; Matsui H; Aki D; Matsunaga T; Inukai T; Goto H; Altura RA; Sugita K; Arisaka O; Look AT; Inaba T
J Biol Chem; 2010 Jan; 285(3):1850-60. PubMed ID: 19887369
[TBL] [Abstract][Full Text] [Related]
17. The first case of elderly
Takeda R; Yokoyama K; Ogawa M; Kawamata T; Fukuyama T; Kondoh K; Takei T; Nakamura S; Ito M; Yusa N; Shimizu E; Ohno N; Uchimaru K; Yamaguchi R; Imoto S; Miyano S; Tojo A
Leuk Lymphoma; 2019 Nov; 60(11):2821-2824. PubMed ID: 31058556
[No Abstract] [Full Text] [Related]
18. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
Baudis M; Prima V; Tung YH; Hunger SP
Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.
Zhang X; Inukai T; Hirose K; Akahane K; Kuroda I; Honna-Oshiro H; Kagami K; Goi K; Nakamura K; Kobayashi M; Endo M; Yagita H; Kurosawa H; Thomas Look A; Honda H; Inaba T; Nakazawa S; Sugita K
Leukemia; 2012 Dec; 26(12):2483-93. PubMed ID: 22743623
[TBL] [Abstract][Full Text] [Related]
20. Pediatric acute lymphoblastic leukemia with t(1;19)/TCF3-PBX1 in Taiwan.
Yen HJ; Chen SH; Chang TY; Yang CP; Lin DT; Hung IJ; Lin KH; Chen JS; Hsiao CC; Chang TT; Chang TK; Peng CT; Lin MT; Jaing TH; Liu HC; Jou ST; Lu MY; Cheng CN; Sheen JM; Chiou SS; Hung GY; Wu KH; Yeh TC; Wang SC; Chen RL; Chang HH; Yang YL; Chen SH; Cheng SN; Chang YH; Chen BW; Hsieh YL; Huang FL; Ho WL; Wang JL; Chang CY; Chao YH; Lin PC; Chen YC; Liao YM; Lin TH; Shih LY; Liang DC
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28436581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
